tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rezolute’s Promising Outlook: Buy Rating Backed by Strong Clinical Progress and Financial Position
PremiumRatingsRezolute’s Promising Outlook: Buy Rating Backed by Strong Clinical Progress and Financial Position
2M ago
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug
Premium
The Fly
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug
2M ago
Rezolute, Inc. (RZLT) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Rezolute, Inc. (RZLT) Q3 Earnings Cheat Sheet
3M ago
Rezolute’s Promising Clinical Developments and Positive Outlook: A Buy Recommendation by Yun Zhong
PremiumRatingsRezolute’s Promising Clinical Developments and Positive Outlook: A Buy Recommendation by Yun Zhong
3M ago
Rezolute Receives Positive DMC Recommendation for Phase 3 Study
Premium
Company Announcements
Rezolute Receives Positive DMC Recommendation for Phase 3 Study
3M ago
Rezolute prices 20.79M shares at $3.25 in underwritten offering
Premium
The Fly
Rezolute prices 20.79M shares at $3.25 in underwritten offering
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100